Clinical and radiological findings of glioblastomas harboring a BRAF V600E mutation

Louis DN, Perry A, Reifenberger G et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820

Article  Google Scholar 

Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. https://doi.org/10.1093/neuonc/noab106

Article  PubMed  Google Scholar 

Taslimi S, Ye VC, Zadeh G (2021) Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 2 newly diagnosed disease. Neurooncol Adv 3:vdab08

Google Scholar 

Chappe C, Padovani L, Scavarda D et al (2013) Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression. Brain Pathol 23:574–583

Article  Google Scholar 

Myung JK, Cho H, Park CK et al (2012) Analysis of the BRAF(V600E) mutation in central nervous system tumors. Transl Oncol 5:430–436

Article  Google Scholar 

Schindler G, Capper D, Meyer J et al (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121:397–405

CAS  Article  Google Scholar 

Lee D, Cho YH, Kang SY et al (2015) BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas. J Surg Oncol 111:359–364

CAS  Article  Google Scholar 

Arita H, Yamasaki K, Matsushita Y et al (2016) A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas. Acta Neuropathol Commun 4:79

Article  Google Scholar 

Hatae R, Hata N, Suzuki SO et al (2017) A comprehensive analysis identifies BRAF hotspot mutations associated with gliomas with peculiar epithelial morphology. Neuropathology 37:191–199

CAS  Article  Google Scholar 

Park CK, Lee SH, Kim JY et al (2014) Expression level of hTERT is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma. Oncotarget 5:3399–3407

Article  Google Scholar 

Zhang RQ, Shi Z, Chen H et al (2016) Biomarker-based prognostic stratification of young adult glioblastoma. Oncotarget 7:5030–5041

Article  Google Scholar 

Kleinschmidt-DeMasters BK, Aisner DL, Birks DK et al (2013) Epithelioid GBMs show a high percentage of BRAF V600E mutation. Am J Surg Pathol 37:685–698

Article  Google Scholar 

Sun K, Zhou X, Li T et al (2021) Clinicopathological characteristics and treatment outcomes of epithelioid glioblastoma. Neurosurg Rev. https://doi.org/10.1007/s10143-021-01492-7

Article  PubMed  PubMed Central  Google Scholar 

Louis DN, Giannini C, Perry A et al (2021) Glioblastoma, IDH-wildtype. In: WHO Classification of Central nervous system tumours [Internet], 5th edn. International Agency for Research on Cancer, Lyon (France). https://tumourclassification.iarc.who.int/chapters/45

Nakajima N, Nobusawa S, Nakata S et al (2017) BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity. Brain Pathol. https://doi.org/10.1111/bpa.12572

Article  PubMed  PubMed Central  Google Scholar 

Dono A, Vu J, Anapolsky M et al (2020) Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses. J Neurooncol 149:463–472

CAS  Article  Google Scholar 

Johanns TM, Ferguson CJ, Grierson PM et al (2018) Rapid clinical and radiographic response with combined dabrafenib and trametinib in adults with BRAF-mutated high-grade glioma. J Natl Compr Canc Netw 16:4–10

Article  Google Scholar 

Kaley T, Touat M, Subbiah V et al (2018) BRAF inhibition in BRAF(V600)-mutant gliomas: results from the VE-BASKET study. J Clin Oncol 36:3477–3484

CAS  Article  Google Scholar 

Kanemaru Y, Natsumeda M, Okada M et al (2019) Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy. Acta Neuropathol Commun 7:119

Article  Google Scholar 

Kushnirsky M, Feun LG, Gultekin SH et al (2020) Prolonged Complete response with combined dabrafenib and trametinib after BRAF Inhibitor failure in BRAF-mutant glioblastoma. JCO Precis Oncol 2020:4

Google Scholar 

Lin Z, Xu H, Yang R et al (2021) Effective treatment of a BRAF V600E-mutant epithelioid glioblastoma patient by vemurafenib: a case report. Anticancer Drugs. https://doi.org/10.1097/cad.0000000000001130

Article  PubMed  PubMed Central  Google Scholar 

Qin C, Long W, Zhang C et al (2020) Multidisciplinary therapy managed recurrent glioblastoma in a BRAF-V600E mutant pregnant female: a case report and review of the literature. Front Oncol 10:522816

Article  Google Scholar 

Robinson GW, Orr BA, Gajjar A (2014) Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy. BMC Cancer 14:258

Article  Google Scholar 

Venkatesh A, Joshi A, Allinson K et al (2021) Response to BRAF and MEK1/2 inhibition in a young adult with BRAF V600E mutant epithelioid glioblastoma multiforme: a case report and literature review. Curr Probl Cancer. https://doi.org/10.1016/j.currproblcancer.2020.100701:100701

Article  PubMed  Google Scholar 

Woo PYM, Lam TC, Pu JKS et al (2019) Regression of BRAF (V600E) mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: a report of two cases. Oncotarget 10:3818–3826

Article  Google Scholar 

Ebi H, Bando H (2019) Precision oncology and the universal health coverage system in Japan. JCO Precis Oncol 2019:3

Google Scholar 

Louis DN, Ohgaki H, Wiestler OD et al (2016) WHO classification of tumours of the central nervous system. Revised 4th edition Edition. In: International Agency for Research on Cancer, Lyon

Ishi Y, Takamiya S, Seki T et al (2020) Prognostic role of H3K27M mutation, histone H3K27 methylation status, and EZH2 expression in diffuse spinal cord gliomas. Brain Tumor Pathol. https://doi.org/10.1007/s10014-020-00369-9

Article  PubMed  Google Scholar 

Lim-Fat MJ, Song KW, Iorgulescu JB et al (2021) Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma. J Neurooncol 152:515–522

CAS  Article  Google Scholar 

McNulty SN, Schwetye KE, Ferguson C et al (2021) BRAF mutations may identify a clinically distinct subset of glioblastoma. Sci Rep 11:19999

CAS  Article  Google Scholar 

Natsumeda M, Chang M, Gabdulkhaev R et al (2021) Predicting BRAF V600E mutation in glioblastoma: utility of radiographic features. Brain Tumor Pathol. https://doi.org/10.1007/s10014-021-00407-0

Article  PubMed  Google Scholar 

Nonoguchi N, Ohta T, Oh JE et al (2013) TERT promoter mutations in primary and secondary glioblastomas. Acta Neuropathol 126:931–937

CAS  Article  Google Scholar 

Suzuki Y, Takahashi-Fujigasaki J, Akasaki Y et al (2015) BRAF V600E-mutated diffuse glioma in an adult patient: a case report and review. Brain Tumor Pathol. https://doi.org/10.1007/s10014-015-0234-4

Article  PubMed  Google Scholar 

Fernandez-Vega I, Quirk J, Norwood FL et al (2014) Gliomatosis cerebri type 1 with extensive involvement of the spinal cord and BRAF V600E mutation. Pathol Oncol Res 20:215–220

CAS  Article  Google Scholar 

Tanaka S, Nakada M, Nobusawa S et al (2014) Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation. Brain Tumor Pathol 31:172–176

Article  Google Scholar 

Watanabe N, Ishikawa E, Kohzuki H et al (2020) Malignant transformation of pleomorphic xanthoastrocytoma and differential diagnosis: case report. BMC Neurol 20:21

CAS  Article  Google Scholar 

Joseph DM, O’Neill AH, Chandra RV et al (2017) Glioblastoma presenting as spontaneous intracranial haemorrhage: case report and review of the literature. J Clin Neurosci 40:1–5

Article  Google Scholar 

Chi AS, Batchelor TT, Yang D et al (2013) BRAF V600E mutation identifies a subset of low-grade diffusely infiltrating gliomas in adults. J Clin Oncol 31:e233-236

Article  Google Scholar 

留言 (0)

沒有登入
gif